| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4705 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
| filingDate |
1998-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3a96f401360ec5479833ec08dcfee56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92eab55ef0a9eb8fde34c3d79d9e9471 |
| publicationDate |
1998-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9831804-A1 |
| titleOfInvention |
NEURONAL bHLH-PAS DOMAIN PROTEINS |
| abstract |
The invention provides methods and compositions relating to neuronal PAS domain proteins (NPAS) and related nucleic acids. The proteins may be produced recombinantly from transformed host cells from the disclosed NPAS encoding nucleic acids or purified from human cells. The invention provides isolated NPAS hybridization probes and primers capable of specifically hybridizing with the disclosed NPAS gene, NPAS-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceutical industry. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0210200-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9928464-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9928464-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0210200-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1354946-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7129065-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7501489-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1354946-A4 |
| priorityDate |
1997-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |